A human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 and its application
By establishing the human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 and its progeny cell lines, the shortcomings in the research and treatment of cholangiocarcinoma sarcoma have been addressed. A stable cell model has been provided for studying the pathogenesis of cholangiocarcinoma sarcoma and drug screening, and for guiding clinical treatment.
Patent Information
- Application Number
- CN202310941999.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-07-29
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2043-07-29
AI Technical Summary
The current lack of effective primary cell lines for cholangiocarcinoma sarcoma has resulted in insufficient research and treatment options.
We established the human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 and its progeny cell lines. The cell lines were obtained through surgical isolation and culture. They were used to study the pathogenesis, development and metastasis of cholangiocarcinoma sarcoma, construct animal models, screen therapeutic drugs, and provide drug-resistant cell models and biomarkers.
This study provides a stable, Chinese-derived cholangiocarcinoma sarcoma cell model with good proliferation, invasion, and migration capabilities. The cells can form tumors in mice and are used to study the pathogenesis and drug sensitivity of cholangiocarcinoma sarcoma, guiding clinical treatment.
Smart Images

Figure CN117004571B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology, and in particular relates to application of a human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 and its progeny cell lines. Background Art
[0002] Cholangiocarcinoma sarcoma is a rare malignant tumor of the bile duct, which is composed of carcinoma and sarcoma. Carcinosarcoma is more common in elderly patients, and is more common in the esophagus, thyroid, breast, lung, bladder, pancreas, ovary, less common in the liver and gallbladder, and even less common in the bile duct. Cholangiocarcinoma sarcoma with chondrocytes is clinically rare, with poor tumor differentiation, strong invasiveness, and extremely poor prognosis. The pathological characteristics of carcinosarcoma are that the tumor tissue has both epithelial and mesenchymal components. The sarcoma component is usually composed of undifferentiated spindle cells and a variety of heterogeneous components, such as cartilage, bone, smooth muscle, and rhabdomyosarcoma cells. The cancer component is usually composed of adenocarcinoma, and there are few squamous cell carcinomas, small cell carcinomas, and undifferentiated carcinomas. The boundaries between tissues are clear and there is no transformation. There are many hypotheses for the pathogenesis of cholangiocarcinosarcoma. The most common theory is the "totipotent stem cell theory", that is, the monoclonal hypothesis, and carcinosarcoma originates from poorly differentiated totipotent stem cells. There are also theories such as the "collision tumor theory" and the "metaplasia theory", that is, the polyclonal hypothesis, which believes that in the same tissue, epithelial cells and mesenchymal cells proliferate malignantly or metaplasia into sarcomas. The recent new hypothesis "epithelial-mesenchymal transition (EMT)" believes that during the EMT process, cancer cells lose epithelial characteristics and cell-to-cell adhesion, transform into mesenchymal cells, and gain migration ability. However, the pathogenesis of bile duct carcinosarcoma is still unclear, and there is no research on the treatment plan to eliminate bile duct carcinosarcoma.
[0003] Cell lines are an effective in vitro model system that can be used to evaluate the characteristics of cancer cells, and based on their characteristics, the cells become direct descendants of the primary tumor. The establishment of cell lines for cholangiocarcinoma is relatively mature. For example, the invention patent CN104560878B established the human intrahepatic cholangiocarcinoma cell line LICCF, which provides an experimental basis for revealing the drug resistance mechanism of human intrahepatic cholangiocarcinoma, reversing the emergence of drug resistance, developing new anticancer drugs, and screening human intrahepatic cholangiocarcinoma-related biomarkers. The invention patent CN115125213A established the intrahepatic cholangiocarcinoma cell line mIC-22, filling the gap in the current domestic research on intrahepatic cholangiocarcinoma lacking a stable in vitro and in vivo mouse model, and can be directly used for the construction of in vitro and in vivo mouse intrahepatic cholangiocarcinoma models. However, a reasonable and effective primary cell line for cholangiocarcinoma sarcoma has not yet been established.
[0004] In response to the above technical problems, the inventor's research group obtained a bile duct carcinoma specimen during surgery and successfully isolated and extracted the primary cell line of bile duct carcinoma, achieving a zero breakthrough in bile duct carcinoma cell lines. This provides an excellent experimental model for studying bile duct carcinoma and has high clinical value. Summary of the invention
[0005] The primary purpose of the present invention is to provide a human hilar cholangiocarcinoma sarcoma cell line CBC2T-2. The human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 was deposited in the China Center for Type Culture Collection on August 23, 2022, with the deposit number: CCTCC NO: C2022273.
[0006] The second object of the present invention is to provide a progeny cell line of the human hilar cholangiocarcinoma sarcoma cell line CBC2T-2.
[0007] Preferably, the human hilar cholangiocarcinoma cell line CBC2T-2 has the ability to form tumors subcutaneously in nude mice.
[0008] The third object of the present invention is to provide an application of the cell line, wherein the application is selected from:
[0009] (1) Used to study the pathogenesis, development and metastasis of bile duct carcinoma;
[0010] (2) Used to construct an animal model of human hilar cholangiocarcinoma;
[0011] (3) Screening or evaluating drugs for the treatment of hilar cholangiocarcinoma;
[0012] (4) Construction of drug-resistant cell models;
[0013] (5) Cell reagents for constructing animal models of hilar cholangiocarcinoma;
[0014] (6) Screening for biomarkers or identifying molecular targets related to hilar cholangiocarcinoma; or
[0015] (7) Study the drug resistance mechanism of hilar cholangiocarcinoma.
[0016] The fourth object of the present invention is to provide a method for detecting the activity of a drug in inhibiting human hilar cholangiocarcinoma, the detection method comprising the following steps: administering the drug to be tested to a cell model, wherein the drug that inhibits cell proliferation or causes cell apoptosis after administration is a drug with the activity of inhibiting cholangiocarcinoma, wherein the cell model is the human hilar cholangiocarcinoma cell line CBC2T-2.
[0017] The fifth object of the present invention is to provide a kit for studying and analyzing human hilar cholangiocarcinoma sarcoma cell lines or for establishing an animal model of human hilar cholangiocarcinoma sarcoma cell lines, wherein the kit comprises a container and the cells contained in the container.
[0018] The sixth object of the present invention is to provide a method for preparing the human hilar cholangiocarcinoma sarcoma cell line CBC2T-2, comprising the following steps:
[0019] (1) Specimen collection and preservation: In bile duct tissue, tumor tissue is obtained from the surface part of the tumor where tumor proliferation is active;
[0020] (2) Primary culture: Tumor tissue was washed three times with PBS, mechanically minced, digested with IV collagenase, centrifuged, and washed;
[0021] (3) Purify cells by mechanical scraping: After successful primary culture, epithelial cells and tumor-associated fibroblasts mostly appear at the same time and grow intermixedly. This intermixed growth is often partitioned into sheets, and CAFs grow on the flask wall in small sheets or regional distributions.
[0022] (4) Expansion culture: When the cell confluence reaches more than 80%, subculture is performed, 0.25% trypsin is added to separate the cells from the flask wall to form a cell suspension, and the cells are resuspended by centrifugation and inoculated into a DMEM culture flask containing 10% fetal bovine serum for further culture.
[0023] The beneficial effects of the present invention are:
[0024] (1) The present invention provides a human hilar cholangiocarcinoma cell line CBC2T-2, which is deposited in China Center for Type Culture Collection, with the deposit address being: Wuhan University, Wuhan, China, and the deposit number being CCTCC NO: C2022273.
[0025] (2) Primary cells cultured in vitro from tumor tissues have active cell proliferation, and under the microscope, there are two types of cell morphology: one is the typical polygonal cholangiocarcinoma cell morphology, and the other is the long spindle-shaped sarcoma chondrosarcoma cell morphology.
[0026] (3) The human hilar cholangiocarcinoma cell line CBC2T-2 has been passaged to about 100 generations, and is in good growth condition. The cells still have good vitality after cryopreservation and recovery, and can be immortalized. The cell doubling time is about 47.11 hours. The human cholangiocarcinoma cell line CBC2T-2 is clinically diagnosed as hilar cholangiocarcinoma (poorly differentiated adenocarcinoma 90%, chondrosarcoma 10%). The human cholangiocarcinoma cell line CBC2T-2 has both epithelial and mesenchymal characteristics in clinical diagnosis, that is, it expresses epithelial components such as CK19 and mesenchymal components such as Vimention, Desmin, CD117 and CD56.
[0027] (4) This cell line is of Chinese origin and was established relatively recently, with stable biological genetic traits. Using this human hilar cholangiocarcinoma cell line CBC2T-2 as a research model is of great help in understanding the pathogenesis of human hilar cholangiocarcinoma.
[0028] (5) When the human hilar cholangiocarcinoma cell line CBC2T-2 was tested by a mycoplasma detection kit, the PCR result was negative and was not contaminated by mycoplasma; the cell line has strong proliferation, healing, invasion and migration capabilities and can be used to study the pathogenesis of human hilar cholangiocarcinoma.
[0029] (6) The human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 described in the present invention can form tumors in mice and has tumorigenicity, and can provide new experimental materials for studying the correlation between sensitivity and resistance of anticancer drugs in vitro, in vivo and clinically. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 Morphological results of human hilar cholangiocarcinoma cell line CBC2T-2 Note: A is the bright field morphology of CBC2T-2 cells at the primary, 1st, 10th, 20th and 50th generations (A 100 times); B is the ultrastructure of cells observed by SEM and TEM electron microscopes (500 times, 1500 times, 3000 times); C is the flow cytometry of CBC2T-2 cells; DE is the growth curve of CBC2T-2 cells.
[0031] Figure 2 Results of spheroidization, migration and invasion of human hilar cholangiocarcinoma cell line CBC2T-2 Note: A is a representative image of spheroidization of CBC2T-2 cells on day 7 and day 14; BC is the scratch healing results of CBC2T-2 and TFK-1 cells after 24 and 48 hours; D is a representative image of migration and invasion of CBC2T-1 and TFK-1 cells detected by Transwell assay; EF is a representative image of clone formation of CBC2T-1 and TFK-1 cells. (A, B, D, E are magnified 100 times).
[0032] Figure 3 Cytogenetic analysis and STR characteristics Note: A is the chromosome karyotype analysis showing that the cells are polyploid, with differences in chromosome structure and number; B is the short segment repeat sequence (STR) identification result of CBC2T-2 cells.
[0033] Figure 4Results of tumor formation experiment of human hilar cholangiocarcinoma cell line CBC2T-2 Note: A is tumor specimen; B is tumor volume growth curve; C is mouse weight growth curve; D is immunohistochemistry of primary tumor tissue of patient, mouse transplanted tumor and cell line CBC2T-2 (100 times)
[0034] Figure 5 To test the inhibitory effects of multiple first-line therapeutic drugs on the human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 in vitro. Note: A is the drug inhibition curve of paclitaxel; B is the drug inhibition curve of gemcitabine; C is the drug inhibition curve of 5-fluorouracil (5-Fu); D is the drug inhibition curve of cisplatin; E is the drug inhibition curve of oxaliplatin. DETAILED DESCRIPTION
[0035] In order to enable those skilled in the art to better understand the solution of the present application, the technical solution in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.
[0036] The experimental methods in the following examples without specifying specific conditions were carried out according to conventional methods and conditions, or selected according to the product instructions.
[0037] Example 1. Establishment of human hilar cholangiocarcinoma cell line
[0038] The specimens were collected under the guidance of the pathologist to avoid affecting the diagnosis of the pathology report. Phosphate buffered saline solution was used to cut the specimens into 1-2 mm pieces with a sterile blade. 3 Blocks were made and preserved in a 37°C incubator with type IV collagenase (0.1 mg / ml) for 10 min. The precipitates were then inoculated in 6-well plates in a certain ratio (10% fetal bovine serum (FBS; 1% penicillin and streptomycin (Gibco), 89% Dulbecco's modified Eagle medium: F-12 (DMEM / F-12). The cells were cultured in a humidified incubator at 37°C and 5% CO2. During continuous culture, the cells were passaged regularly and frozen in liquid nitrogen regularly. There was no contamination from other cells or foreign microorganisms during the culture process. No exogenous growth factors or stimulatory cytokines were added during the establishment of the cell line CBC2T-2.
[0039] The cell line CBC2T-2 was named human hilar cholangiocarcinoma sarcoma cell line CBC2T-2, and was deposited in the China Center for Type Culture Collection on August 23, 2022. The deposit address is: Wuhan University, Wuhan, China, deposit number: CCTCCNO: C2022273, telephone: 027-68752319; E-mail: cctcc@whu.edu.cn.
[0040] Example 2: Microscopic examination of human hilar cholangiocarcinoma cell line CBC2T-2
[0041] Hematoxylin and eosin staining showed that the hilar bile duct carcinoma sarcoma (poorly differentiated adenocarcinoma 90%, chondrosarcoma 10%) showed epithelial dysplasia under the microscope, with cord-like, nest-like, and glandular arrangements. The cells were enlarged, with large and darkly stained nuclei. Pathological nuclear division images were seen. A large amount of mucus and mucous cartilage were seen locally. The cancer cells infiltrated and grew, invading the surrounding adipose tissue. Neural invasion and intravascular tumor emboli were seen. Metastatic carcinoma was seen in the surrounding lymph nodes (1 / 1). AJCC-pTNM staging: T2aN2Mx. Metastatic carcinoma was seen in group 7 lymph nodes (2 / 4). Histology showed two clearly separated epithelial and mesenchymal components, namely adenocarcinoma and chondrosarcoma composed of spindle cells.
[0042] like Figure 1 A shows primary cells cultured in vitro from tumor tissue. The cells proliferate actively. Under the microscope, there are two types of cell morphology: one is a typical polygonal cholangiocarcinoma cell morphology, and the other is a long spindle sarcoma chondrosarcoma cell morphology. Figure 1 B. The above cell line has been passaged to about 100 generations and is in good growth condition. The cells still have good vitality after being frozen and revived, and have been immortalized. Figure 1 B Transmission electron microscopy (TEM) showed that the cells contained many mitochondria, rough endoplasmic reticulum, ribosomes and irregular nuclei with deep indentations on the nuclear membrane. Scanning electron microscopy (SEM) showed microvilli-like protrusions, tight junctions and intercellular bridges on the cell surface.
[0043] When the cells are passed for more than 30 generations, the cell traits gradually become stable and relevant biological, genetic and tissue origin identifications can be performed. The cells will have the same stable traits until the 50th generation.
[0044] Example 3 Cell Cycle of Human Hilar Cholangiocarcinoma Cell Line CBC2T-2
[0045] Take tumor cells (p15) in the logarithmic growth phase, wash with PBS, digest with 0.25% trypsin, resuspend in DMEM / F-12 medium containing 10% FBS, and prepare a single cell suspension. Collect in a centrifuge tube and centrifuge at about 1000g for 3-5min to precipitate the cells. Carefully remove the supernatant, and about 50μl of culture medium can remain to avoid sucking away the cells. Add about 1ml of PBS pre-cooled in an ice bath, resuspend the cells, and transfer to a 1.5mL centrifuge tube. Centrifuge again to precipitate the cells, carefully remove the supernatant, and about 50μl of PBS can remain to avoid sucking away the cells. Gently tap the bottom of the centrifuge tube to properly disperse the cells and avoid cell clumping. Cell fixation: Add 1mL of 75-80% ethanol pre-cooled in an ice bath, gently blow and mix. For cells that are easy to clump, add ethanol while shaking to mix. Fix for 1-2h before detection. Wash twice with pre-cooled PBS, centrifuge at 1000 rpm for 5 min, and adjust the cell concentration to 1×10 6 / mL. Add 0.5mL of propidium iodide and stain at 4℃ in the dark for 30min. Use flow cytometry to detect red fluorescence at 535nm excitation wavelength and 615nm emission wavelength, and detect light scattering at the same time. Use appropriate analysis software to analyze cell DNA content and light scattering, and detect 1×10 4 / ml cells.
[0046] like Figure 1 As shown in C, the cell cycle of human hilar cholangiocarcinoma cell line CBC2T-2 cells. The cells proliferate actively and are suitable for in vitro 2D model studies of cholangiocarcinoma.
[0047] Example 4. Doubling time and cell imaging of human hilar cholangiocarcinoma cell line CBC2T-2 cells
[0048] Tumor cells (p15) in the logarithmic growth phase were taken, washed with PBS, digested with 0.25% trypsin, resuspended in DMEM / F-12 medium containing 10% FBS, prepared into single-cell suspension and counted with a platelet counting plate, and a cell suspension with a final concentration of 5000 cells / 100 μl was obtained after concentration adjustment; the cells were inoculated in a 96-well plate, 100 μl per well, 3 replicate wells per group, and the 96-well plate was placed in a Cytation5 cell imaging workstation, and the field of view of each well was selected for shooting, and a picture was taken every 2 hours for 120 hours.
[0049] like Figure 1 D is a real-time live cell imaging growth curve. The human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 of the present invention has a cell doubling time of 47 hours as measured by live cell imaging counting.
[0050] Example 5. Doubling time of human hilar cholangiocarcinoma cell line CBC2T-2 cells
[0051] Tumor cells (p15) in the logarithmic growth phase were taken, washed with PBS, digested with 0.25% trypsin, resuspended in DMEM / F-12 medium containing 10% FBS, prepared into single cell suspension and counted with platelet counting plate, and the final concentration of 5000 / 100μl cell suspension was obtained after concentration adjustment; it was inoculated in a 96-well plate, 100μl per well, 5 replicate wells per group, and 5 replicate wells with only 100μl culture medium added as blank control; placed in a constant temperature incubator, cultured at 37℃, 5% CO2 and saturated humidity. CCK-8 solution was added at a ratio of 1:10 at 0, 24, 48, 72, 96, and 120h, incubated in a 37℃ cell culture incubator for 2h, and then the absorbance was measured at 450nm.
[0052] like Figure 1 As shown in E, the horizontal axis of the cell growth curve is time, and the vertical axis is absorbance. The cell doubling time was calculated using the doubling time software (PDT) (http: / / www.doubling-time.com). The doubling time of CBC2T-2 cells is about 47.11h, and the proliferation time is short, which is suitable for the in vitro 2D model study of bile duct carcinoma sarcoma.
[0053] Example 6: Spheroid-forming ability of human hilar cholangiocarcinoma cell line CBC2T-2
[0054] Take 1×10 5 The cells were digested and inoculated into Corning ultra-low attachment 96-well plates. The cell sphering was monitored at 3, 7, 10, and 14 days after inoculation to detect the cell sphering ability.
[0055] like Figure 2 As shown in A, human hilar cholangiocarcinoma cell line CBC2T-2 was seeded in an ultra-low attachment 96-well plate and observed for 14 days, indicating that the human hilar cholangiocarcinoma cell line CBC2T-2 had the ability to form spheres.
[0056] Example 7. Healing ability of human hilar cholangiocarcinoma cell line CBC2T-2
[0057] The human hilar cholangiocarcinoma cell line CBC2T-2 (p15) in the logarithmic growth phase and the extrahepatic cholangiocyte TFK-1 cells purchased from the company were washed with PBS, digested with 0.25% trypsin, and resuspended in DMEM / F-12 and 1640 medium containing 10% FBS to prepare a single cell suspension. The cells were counted by an automatic cell counter and the final concentration was adjusted to 2×10 6 / ml of cell suspension, take 2ml of cell suspension and inoculate it into a six-well plate. After culturing for 24h, use a 1ml pipette tip to draw a cross vertically in the six-well plate, and wash it three times with PBS. Finally, add DMEM / F-12 medium containing 10% fetal bovine serum for cultivation, and take pictures under an optical microscope after 24h and 48h.
[0058] The results are as follows Figure 2 As shown in BC, the healing ability of human hilar cholangiocarcinoma cell line CBC2T-2 cells was significantly stronger than that of human extrahepatic cholangiocarcinoma cell line TFK-1 cells.
[0059] Example 8: Migration and invasion ability of human hilar cholangiocarcinoma cell line CBC2T-2 cells
[0060] Human hilar cholangiocarcinoma cell line CBC2T-2 (p20) and extrahepatic cholangiocyte TFK-1 cells in the logarithmic growth phase were washed with PBS, digested with 0.25% trypsin, and resuspended in DMEM / F-12 and 1640 medium containing 10% FBS to prepare a single cell suspension. Transferred to a centrifuge tube and centrifuged (1000r / 5min), resuspended with sterile PBS and centrifuged three times, and finally resuspended in serum-free DMEM / F-12 medium and 1640 medium, respectively. Counted by an automatic cell counter, the final concentration was 1×10 5 / ml cell suspension; when detecting the migration ability of cells, spread 200μl of cell suspension in the upper chamber of transwell without matrix gel; when detecting the invasion ability of cells, spread 200μl of cell suspension in the upper chamber of transwell with matrix gel (the gel can be laid 30 minutes in advance for use, the concentration is serum-free culture medium and gel ratio is 1:10, add about 40μl to each upper chamber, and suck out the excess liquid after solidification). The upper chambers are placed in 24-well plates containing DMEM / F-12 culture medium containing 15% fetal bovine serum and 1640 culture medium, respectively, and placed in a cell culture incubator. After culturing for 24h and 48h respectively, the upper chambers are taken out and fixed in 4% paraformaldehyde for 20min, and then the cells on the upper layer of the chamber that have not passed through the transwell membrane are wiped off with a cotton swab. After staining with 0.1% crystal violet solution for 20min, wash with PBS, and then observe and photograph under an inverted microscope.
[0061] like Figure 2 As shown in D, the migration and invasion abilities of human hilar cholangiocarcinoma cell line CBC2T-2 cells were stronger than those of extrahepatic cholangiocyte TFK-1 cell line at 24h and 48h.
[0062] Example 9: Cloning ability of human hilar cholangiocarcinoma cell line CBC2T-2 cells
[0063] Human hilar cholangiocarcinoma cell line CBC2T-2 (p25) and extrahepatic cholangiocyte TFK-1 cells in logarithmic growth phase were washed with PBS, digested with 0.25% trypsin, and resuspended in DMEM / F-12 and 1640 culture medium containing 10% FBS to prepare single cell suspension. After counting with an automatic cell counter, the concentration was adjusted to obtain a cell suspension with a final concentration of 800 / 2ml; the cell suspension of the above concentration was inoculated into a 6-well plate, 2ml per well, and placed in an incubator for continued culture, and the culture medium was changed every 3 days. After 2 weeks, the cells were placed under an inverted optical microscope for observation and photography. The culture medium was then discarded, washed 3 times with PBS, fixed in 4% paraformaldehyde for 20 minutes, and then stained with 0.5% crystal violet solution for 20 minutes, then washed clean under clean water, and then placed under an inverted microscope (ZEISS) for photography and counting.
[0064] like Figure 2 As shown in EF, the migration and cloning ability of human hilar cholangiocarcinoma cell line CBC2T-2 cells was significantly stronger than that of extrahepatic cholangiocytes TFK-1.
[0065] Example 10: Chromosome Karyotype Analysis of Human Hilar Cholangiocarcinoma Cell Line CBC2T-2
[0066] The human hilar cholangiocarcinoma cell line CBC2T-2 of the present invention is incubated in a logarithmic growth phase (p25) in a standard culture medium containing 10 μg / ml colchicine for 2 hours. After discarding the culture medium, the cells are washed with PBS and digested with trypsin to collect the cells. After washing with PBS and centrifuging, the cells are collected at the bottom of a 15 ml centrifuge tube and treated with a 0.075 M potassium chloride solution at low tension for 30 minutes in a 37° C. water bath. Directly add 1 ml of freshly prepared fixative (methanol: glacial acetic acid, 3:1, V / V) to the above hypotonic solution, gently blow evenly, fix for 5 minutes and then centrifuge (2000rpm, 10min), and discard the supernatant; add 6-8 ml of freshly prepared fixative again, and fix at room temperature for 30 minutes; after centrifugation of the above specimens, add 5-6 drops of fixative, take 1 drop, drop it on a 4°C distilled water slide, quickly bake and blow the slide over the flame of an alcohol lamp; add an appropriate amount of Giemsa working solution to the surface of the blown slide and stain it for 10-15 minutes, rinse the slide with tap water and dry it naturally to obtain the metaphase chromosome specimen.
[0067] like Figure 3 As shown in A, chromosomes were prepared using standard methods, and the chromosome numbers were mostly distributed through G banding. Images of representative chromosome sets were obtained for karyotype analysis, and the interpretation of karyotypes was based on the International System for Cytogenetic Nomenclature (ISCN). Figure 3A shows the karyotype analysis of a representative single cell of the human hilar cholangiocarcinoma cell line CBC2T-2. The chromosome number and structure of the human hilar cholangiocarcinoma cell line CBC2T-2 were abnormal. The chromosomes of the cell line were polyploid, with the number of chromosomes ranging from 69 to 73. The structural abnormalities included chromosome gain, deletion and translocation.
[0068] Example 11: STR loci of human hilar cholangiocarcinoma cell line CBC2T-2 cells
[0069] Short tandem repeat (STR), also known as microsatellite DNA, refers to a type of DNA sequence on chromosomes that is formed by tandem repetitions of several base pairs as core units (2-6 base pairs) (the number of repetitions is 10-60 times, and the gene fragment is less than 400 base pairs); the number of times each core unit is repeated will vary from individual to individual, thus forming alleles with different fragment lengths. Therefore, the number of repetitions of a set of STR sequences is almost unique in different individuals, which is an individual's genetic identity characteristic and the main method for cell biology to identify cell identity and origin.
[0070] Freshly cultured human cholangiocarcinoma cell line CBC2T-2 cells were collected, and the genomic DNA of the cells was extracted using Tsingke's animal genome extraction kit (Cat. No. TSP201-200). PCR amplification was performed using 5'-end fluorescently labeled primers, and the resulting products were sequenced to analyze the sequence repeat numbers of 21 STR loci including AMEL, D19S433, D5S818, D21S11, D18S51, D6S1043, D3S1358, D13S317, and Penta D.
[0071] like Figure 3 As shown in Figure B, the human bile duct carcinoma sarcoma cell line CBC2T-2 of the present invention adopts the most authoritative detection method, which is the STR detection method recommended by ATCC. The detection results confirm that the bile duct carcinoma sarcoma cell lines are all human in origin. Compared with the cell genetic information in the three most famous culture collections in the world, ATCC, DSMZ and CELLOSAURUS, there is no sequence matching with other cells, proving that it is not contaminated by other cells.
[0072] Example 12: Subcutaneous tumor formation experiment in mice
[0073] Tumor cells (p30) in the logarithmic growth phase were washed with PBS, digested with 0.25% trypsin, and resuspended in DMEM / F-12 medium containing 10% FBS to prepare a single cell suspension by centrifugation (1000 rpm, 5 min). The cell pellet was washed with PBS and centrifuged three times, and the cells were resuspended in DMEM / F-12 and counted to adjust the cell density K to 1×10 7 / ml; 1 ml of the above cell suspension was injected subcutaneously into the axilla of 4-week-old NOD / SCID mice (n=3), and the mice were housed in an SPF-grade laminar flow animal room; the mice were observed for 7 weeks, and the tumor diameter was measured every 5 days; after 8 weeks, the mice were euthanized, the tumors were removed for measurement and photography, and part of the tumor was immersed in 10% formalin solution for routine paraffin embedding and sectioning for later use.
[0074] like Figure 4 As shown in Figures AC, the experimental results show that the established cell lines have good in vitro tumorigenicity in nude mice. The cell lines were established from Chinese people, with a short establishment time and stable biological genetic traits. Using the human hilar cholangiocarcinosarcoma cell line CBC2T-2 as a research model is very helpful for understanding the pathogenesis of carcinosarcoma in the Chinese population.
[0075] Example 13: Immunohistochemistry experiment
[0076] Preparation of cell slides: Clean the coverslip with detergent, then rinse it off with tap water, rinse it three times with pure water, soak it in 75% alcohol and let it stand for 10 minutes. Use tweezers to pick up a 24mm*24mm coverslip and burn the alcohol on an alcohol lamp. The temperature should not be too high. Place the burned coverslip in a six-well plate and add the cell suspension (about 2×10 4 100 cells) were dripped onto the coverslip. 1 ml of culture medium was gently added after 5 hours, and the cells were cultured overnight in a 37°C 5% CO2 incubator. The cells adhered to the slide and grew well.
[0077] Fixation: Wash the prepared slides twice with PBS solution, add 1 ml of 4% paraformaldehyde solution to each well of the six-well plate, and let it stand for 10-15 minutes. (2) Aspirate the excess 4% paraformaldehyde solution, and then add 500 μl of PBS solution.
[0078] Baking: The mouse tumor tissue sections, human hilar cholangiocarcinoma cell line CBC2T-2, and primary tumor tissue sections of the cell-derived patient were baked at 70°C for 1 hour.
[0079] Dewaxing: Transfer the slides to xylene and dewax in sequence: xylene I for 10 min, xylene II for 10 min, and xylene III for 10 min.
[0080] Hydration: 100% ethanol I for 1 min, 100% ethanol II for 1 min, 95% ethanol for 1 min, 85% ethanol for 1 min, 75% ethanol for 1 min, and then washed 3 times with purified water.
[0081] Antigen repair: Heat 0.01M citrate buffer in a pressure cooker until boiling, put the slices in, boil for 2 and a half minutes, and then cool to room temperature; after repair, take out the slices and place them in PBS and wash them 3 times with PBS, 2 minutes each time.
[0082] Endogenous peroxidase blocking: add endogenous peroxidase blocker to the sections, incubate at room temperature for 10 min, and wash the slides in PBS three times, 2 min each time.
[0083] Blocking: Block with goat serum for 10 min.
[0084] Incubate with primary antibody: After discarding the blocking solution, place the plate in a humidified box, add the corresponding primary antibody, and incubate overnight at 4°C.
[0085] Incubation with secondary antibody: discard the primary antibody the next day, wash with PBS three times, 2 min each time, transfer to a wet box, add secondary antibody, and incubate at room temperature for 30 min.
[0086] DAB staining: Wash with PBS 3 times, 2 minutes each time. Add DAB for 1-5 minutes, stop color development in time, transfer to a slide rack, and wash with double distilled water for 5 minutes.
[0087] Hematoxylin staining: Soak in hematoxylin stain for 5 minutes, then rinse with purified water, then differentiate with hydrochloric acid alcohol differentiation solution for a few seconds, rinse with purified water immediately after differentiation, and finally place the slices in running water to rinse for 5 minutes.
[0088] Dehydration and sealing: Place the slices in 75% ethanol, 85% ethanol, 95% ethanol, and anhydrous ethanol for 1 min each. After drying, add neutral gum on the slices and cover with a coverslip.
[0089] like Figure 4 As shown in D, H&E and IHC staining were used to observe the tumorigenesis of mouse transplanted tumors, CBC2T-2 (P30) cells, and primary tumor tissues of patients. The results of H&E staining confirmed that the histological consistency was ( Figure 4 D, first row). IHC staining showed that the tissue and cells locally expressed keratin (CK19), an epithelial marker. Sarcoma component markers such as Vimentin, Desmin, CD117 and CD68, and S-100 protein were positively expressed. We demonstrated that the primary tumor tissue has both epithelial (carcinoma) and mesenchymal (chondrosarcoma) components. In conclusion, the CBC2T-2 cell line will be a valuable tool for studying cholangiocarcinosarcoma in vitro and in vivo.
[0090] Example 14: Drug Screening in Human Hilar Cholangiocarcinoma Cell Line CBC2T-2 Cells
[0091] Human hilar cholangiocarcinoma cell line CBC2T-2 cells (p30) in logarithmic growth phase were taken, washed with PBS, digested with 0.25% trypsin, resuspended in DMEM / F-12 medium containing 10% FBS, prepared into single cell suspension and counted with platelet counting plate, and the final concentration of cell suspension was 10000 / 100 μl after concentration adjustment; inoculated in 96-well plate, 100 μl per well, 5 replicate wells per group, and 5 replicate wells with only 100 μl culture medium added as blank control; after the inoculated cells were cultured for 24 hours to adhere to the wall, appropriate amount of chemotherapy gemcitabine (Gemcitabine) and oxaliplatin (Oxaliplation), cisplatin (Cis-platinum), paclitaxel (Paclitaxelcis) and 5-fluorouracil (5-Fluorouracil) were added to each group, different concentrations of drugs were set, and the cells were placed in an incubator and continued to be cultured for 72 hours.
[0092] After the cells were cultured with drugs for 72 hours, each group of cells was tested for activity using CCK-8 (1:10 dilution, incubated at 37°C for 2 hours), and the absorbance value of each group of cells at 450nm was recorded. The curve was drawn using Graphpad software and the IC50 value was calculated.
[0093] Use an enzyme-labeled instrument to detect the absorbance (OD value) at a wavelength of 450 nm and calculate according to the formula:
[0094] Cell viability (%) = [(As-Ab) / (Ac-Ab)] × 100%
[0095] Note: As: absorbance of the experimental group (including cells, culture medium, CCK-8 solution and drug solution); Ac: absorbance of the control group (including cells, culture medium, CCK-8 solution, but not containing drugs); Ab: absorbance of the blank group (including culture medium and CCK-8 solution, but not containing cells or drugs).
[0096] The results are as follows Figure 5 As shown in AE, among the chemotherapy drugs, oxaliplatin (IC50=77.51μM), paclitaxel (IC50=0.002197μM), 5-fluorouracil (IC50=7.516μM), cisplatin (IC50=19.24μM) and gemcitabine (IC50=0.0095μM) all inhibited CBC2T-2 cells, among which paclitaxel was the most sensitive to the cells, followed by gemcitabine. This drug screening provides clinical treatment information for patients with cholangiocarcinoma and guides clinical drug use. The combination of gemcitabine and paclitaxel is the most sensitive treatment.
[0097] In summary, when the human hilar cholangiocarcinoma cell line CBC2T-2 cells were detected by a mycoplasma detection kit, the PCR result was negative and was not contaminated by mycoplasma; the human hilar cholangiocarcinoma cell line CBC2T-2 cells had strong proliferation, healing, invasion and migration abilities and could be used to study the pathogenesis of hilar cholangiocarcinoma. The human hilar cholangiocarcinoma cell line CBC2T-2 of the present invention can successfully prepare an animal model of cholangiocarcinoma, and the prepared animal model can be used for basic research and drug screening, and provide new experimental materials for in vivo experiments in preclinical studies and tests of sensitivity and resistance of clinical anticancer drugs.
[0098] The above-mentioned specific implementation methods are used to explain the present invention and are only preferred embodiments of the present invention, rather than limiting the present invention. Any modifications, equivalent substitutions, improvements, etc. made to the present invention within the spirit of the present invention and the protection scope of the claims shall fall within the protection scope of the present invention.
Claims
1. A human hilar cholangiocarcinoma cell line CBC2T-2, characterized in that: The human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 was deposited in the China Center for Type Culture Collection on August 23, 2022, with the deposit number: CCTCCNO: C2022273.
2. The human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 according to claim 1, characterized in that The cell line has the ability to form tumors subcutaneously in nude mice.
3. The use of the cell line according to claim 1, characterized in that: The application is selected from: (1) Used to study the pathogenesis, development and metastasis of bile duct carcinoma; (2) Used to construct an animal model of human hilar cholangiocarcinoma; (3) Screening or evaluating drugs for the treatment of hilar cholangiocarcinoma; (4) Construction of drug-resistant cell models; (5) Cell reagents for constructing animal models of hilar cholangiocarcinoma; (6) Screening for biomarkers or identifying molecular targets related to hilar cholangiocarcinoma; or (7) Study the drug resistance mechanism of hilar cholangiocarcinoma.
4. A method for detecting the activity of a drug in inhibiting human hilar cholangiocarcinosarcoma, characterized in that: The detection method comprises the following steps: administering the drug to be tested to a cell model, wherein the drug that inhibits cell proliferation or causes cell apoptosis after administration is a drug with the activity of inhibiting cholangiocarcinoma sarcoma, wherein the cell model is the human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 as described in claim 1.
5. A kit for studying and analyzing human hilar cholangiocarcinoma cell lines or for establishing an animal model of human hilar cholangiocarcinoma cell lines, characterized in that: The kit comprises a container and cells of the human hilar cholangiocarcinoma sarcoma cell line CBC2T-2 according to claim 1 contained in the container.
